[HMG-CoA reductase inhibitors for prevention and treatment of coronary heart disease. Effective reduction of cardiac events and mortality].
Windler
E
E
Kernklinik und Poliklinik, Krankenhaus Eppendorf der Universität, Hamburg.
D003327:Coronary Disease / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D017035:Pravastatin / Q000627:therapeutic use; D015996:Survival Rate; D016896:Treatment Outcome
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D017035:Pravastatin
HMG-CoA-Reduktasehemmer zur Prävention und Behandlung der KHK. Effektive Reduktion von kardialen Ereignissen und Mortalität.